Status:

COMPLETED

Transversus Abdominis and Transversalis Fascia Plane Block Combination for Cesarean Section

Lead Sponsor:

Ataturk University

Conditions:

Ceserean Section and Postoperative Pain

Eligibility:

FEMALE

18-45 years

Phase:

NA

Brief Summary

Cesarean delivery rates are rising globally, and effective postoperative analgesia is crucial for maternal recovery and newborn care. While intrathecal morphine offers strong analgesia, it may cause s...

Eligibility Criteria

Inclusion

  • 18-45 years old
  • American Society of Anesthesiologists physical score I or II
  • caesarean section with a Pfannenstiel incision

Exclusion

  • additional surgical intervention, or received general anaesthesia,
  • hypersensitivity to the agents to be used
  • BMI greater than 35 kg m-2
  • coagulopathy,
  • local infection,
  • opioid addiction,
  • pregnancy-related hypertension
  • diabetes mellitus

Key Trial Info

Start Date :

January 1 2024

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 1 2025

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT06944912

Start Date

January 1 2024

End Date

March 1 2025

Last Update

April 27 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Atatürk University Hospital

Erzurum, Yakutiye, Turkey (Türkiye), 25100